炎症标志物与胰岛素敏感性和分泌的不同关联:前瞻性 METSIM 研究
在前瞻性 METSIM 研究中,对 5401 名芬兰非糖尿病男性随访 6.8 年,评估糖蛋白乙酰基(GlycA)、白细胞介素-1 受体拮抗剂(IL-1RA)和高敏 C 反应蛋白(hs-CRP)与胰岛素分泌、胰岛素敏感性及代谢结局的关联。GlycA 与胰岛素分泌受损、高血糖、2 型糖尿病和心血管疾病相关,IL-1RA 和 hs-CRP 与胰岛素敏感性不良变化及总死亡率相关。
要点
- GlycA 与胰岛素分泌受损、高血糖、2 型糖尿病(HR 1.37)和心血管疾病(HR 1.21)相关。
- IL-1RA 和 hs-CRP 与胰岛素敏感性不良变化及总死亡率相关(HR 分别为 1.13 和 1.08)。
- 三种标志物联合可改善疾病结局预测,提示其反映低度炎症的不同方面。
核心结论
- 炎症标志物可差异化预测胰岛素分泌和胰岛素敏感性的变化:GlycA 预测胰岛素分泌受损,IL-1RA 和 hs-CRP 预测胰岛素敏感性的变化。
- 联合三种标志物可改善疾病结局的预测,提示它们反映低度炎症的不同方面。
研究设计与样本
- 前瞻性研究;横断面 METSIM 研究纳入 8749 名 45 至 73 岁非糖尿病芬兰男性,从芬兰 Kuopio 人口登记中随机选取。
- 共 5401 名男性参与 6.8 年随访研究。
主要发现
- 随访期间,GlycA 与胰岛素分泌受损、高血糖、2 型糖尿病(风险比 1.37;95% 置信区间 1.29 至 1.46)和心血管疾病(风险比 1.21;95% 置信区间 1.12 至 1.32)相关。
- IL-1RA 和 hs-CRP 与胰岛素敏感性及肥胖相关特征的不良变化相关,并与总死亡率相关(风险比 1.13;95% 置信区间 1.07 至 1.20;风险比 1.08;95% 置信区间 1.04 至 1.11)。
关键数值与推荐
- GlycA 与 2 型糖尿病:风险比 1.37;95% 置信区间 1.29 至 1.46。
- GlycA 与心血管疾病:风险比 1.21;95% 置信区间 1.12 至 1.32。
- IL-1RA 与总死亡率:风险比 1.13;95% 置信区间 1.07 至 1.20。
- hs-CRP 与总死亡率:风险比 1.08;95% 置信区间 1.04 至 1.11。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Low-grade inflammation is involved in the development of type 2 diabetes and cardiovascular disease (CVD); however, prospective studies evaluating inflammatory markers as predictors of changes in insulin secretion and insulin sensitivity are lacking. OBJECTIVE: We investigated the associations of glycoprotein acetyls (GlycA), interleukin-1 receptor antagonist (IL-1RA), and high-sensitivity C-reactive protein (hs-CRP) with insulin secretion, insulin sensitivity, incident type 2 diabetes, hypertension, CVD events, and total mortality in the prospective Metabolic Syndrome in Men (METSIM) study. DESIGN: A prospective study. PARTICIPANTS: The cross-sectional METSIM study included 8749 nondiabetic Finnish men aged 45 to 73 years, who had been randomly selected from the population register of Kuopio, Finland. A total of 5401 men participated in the 6.8-year follow-up study. MAIN OUTCOME MEASURES: Changes in insulin secretion, insulin sensitivity, and cardiometabolic traits during the follow-up period and the incidence of type 2 diabetes, hypertension, CVD events, and total mortality. RESULTS: During the follow-up period, GlycA was associated with impaired insulin secretion, hyperglycemia, incident type 2 diabetes (hazard ratio, 1.37; 95% confidence interval, 1.29 to 1.46) and CVD (hazard ratio, 1.21; 95% confidence interval, 1.12 to 1.32). IL-1RA and hs-CRP were associated with adverse changes in insulin sensitivity and obesity-related traits and with total mortality (hazard ratio, 1.13; 95% confidence interval, 1.07 to 1.20; and hazard ratio, 1.08; 95% confidence interval, 1.04 to 1.11, respectively). CONCLUSIONS: Inflammatory markers differentially predicted changes in insulin secretion and insulin sensitivity. GlycA predicted impaired insulin secretion, and IL-1RA and hs-CRP predicted changes in insulin sensitivity. Combining the three markers improved the prediction of disease outcomes, suggesting that they capture different aspects of low-grade inflammation.
引用
- Fizelova M, Jauhiainen R, Kangas AJ, et al. Differential Associations of Inflammatory Markers With Insulin Sensitivity and Secretion: The Prospective METSIM Study. J Clin Endocrinol Metab. 2017. PMID: 28911155. doi:10.1210/jc.2017-01057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。